Form 4: AngioDynamics Director Karen A. Licitra Reports Acquisition of 20,541 Shares

Director Karen A. Licitra reports acquiring 20,541 shares of AngioDynamics common stock as part of annual compensation.

Summary

• Karen A. Licitra, a director of AngioDynamics Inc. (ANGO), filed a Form 4 to report changes in beneficial ownership.
• On July 17, 2024, Licitra acquired 20,541 shares of AngioDynamics common stock.
• These shares were granted as restricted stock units, representing annual compensation for her service as a director.
• The restricted stock units vested immediately upon grant.
• Following the transaction, Licitra directly owns 72,760 shares of AngioDynamics.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports a standard compensation practice. There is no indication of positive or negative performance.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Director compensation in the form of stock options and restricted stock units is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it demonstrates the director's alignment with shareholder interests.

Key Dates